Similar articles

• Antiarrhythmic trials: a decade of growth.

  Kanjwal MY. Kanjwal MY. Indian Heart J. 1998 May-Jun;50(3):277-84. Indian Heart J. 1998. PMID: 9753848 Review. No abstract available.
• Sudden death due to cardiac arrhythmias.

  Huikuri HV, Castellanos A, Myerburg RJ. Huikuri HV, et al. N Engl J Med. 2001 Nov 15;345(20):1473-82. doi: 10.1056/NEJMra000650. N Engl J Med. 2001. PMID: 11794197 Review. No abstract available.
• Antiarrhythmic therapy in heart failure.

  Eckardt L, Haverkamp W, Breithardt G. Eckardt L, et al. Heart Fail Monit. 2002;2(4):110-9. Heart Fail Monit. 2002. PMID: 12634885 Review.
• [Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].

  Ducceschi V, Sarubbi B, Esposito R, Manzo G, Mayer MS, Santangelo L, Iacono A. Ducceschi V, et al. Cardiologia. 1995 May;40(5):355-60. Cardiologia. 1995. PMID: 8529247 Italian. No abstract available.
• Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.

  Kruger A, Aronow WS, Lai H, Desai H, Singla A, Frishman WH, Cohen M, Sorbera C. Kruger A, et al. Am J Ther. 2009 Jul-Aug;16(4):323-5. doi: 10.1097/MJT.0b013e3181727a59. Am J Ther. 2009. PMID: 19617719